La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K

Identifieur interne : 004929 ( Main/Exploration ); précédent : 004928; suivant : 004930

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K

Auteurs : T. Yamada [Canada] ; P. L. Mcgeer [Canada] ; K. G. Baimbridge [Canada] ; E. G. Mcgeer [Canada]

Source :

RBID : ISTEX:4BD7EEE7C9455A85DA6B7926202C569AB07183AF

English descriptors

Abstract

Abstract: The distribution of calbindin-D28K (CaBP)-positive neurons was investigated by immunohistochemistry in 4 controls, 5 cases of Parkinson's disease and a single case of strionigral degeneration. CaBP-positive neurons were preferentially localized to the mediodorsal portion of the substantia nigra pars compacta (SNC) in the β layer, while CaBP-negative, melanin-positive neurons were concentrated in the ventrolateral SNC in the α layer. In Parkinson's disease and the case of strionigral degeneration, there was a relative sparing of the CaBP-positive neurons compared with CaBP-negative, pigmented neurons. These data imply that CaBP may confer some protection to SNC dopaminergic neurons against the pathological process which is responsible for Parkinson's disease and strionigral degeneration.

Url:
DOI: 10.1016/0006-8993(90)91236-A


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K</title>
<author>
<name sortKey="Yamada, T" sort="Yamada, T" uniqKey="Yamada T" first="T." last="Yamada">T. Yamada</name>
</author>
<author>
<name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
</author>
<author>
<name sortKey="Baimbridge, K G" sort="Baimbridge, K G" uniqKey="Baimbridge K" first="K. G." last="Baimbridge">K. G. Baimbridge</name>
</author>
<author>
<name sortKey="Mcgeer, E G" sort="Mcgeer, E G" uniqKey="Mcgeer E" first="E. G." last="Mcgeer">E. G. Mcgeer</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4BD7EEE7C9455A85DA6B7926202C569AB07183AF</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1016/0006-8993(90)91236-A</idno>
<idno type="url">https://api-v5.istex.fr/document/4BD7EEE7C9455A85DA6B7926202C569AB07183AF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001961</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001961</idno>
<idno type="wicri:Area/Istex/Curation">001961</idno>
<idno type="wicri:Area/Istex/Checkpoint">002072</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002072</idno>
<idno type="wicri:doubleKey">0006-8993:1990:Yamada T:relative:sparing:in</idno>
<idno type="wicri:Area/Main/Merge">005249</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2257487</idno>
<idno type="wicri:Area/PubMed/Corpus">001B63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B63</idno>
<idno type="wicri:Area/PubMed/Curation">001B63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B63</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B63</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B63</idno>
<idno type="wicri:Area/Ncbi/Merge">001145</idno>
<idno type="wicri:Area/Ncbi/Curation">001145</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001145</idno>
<idno type="wicri:doubleKey">0006-8993:1990:Yamada T:relative:sparing:in</idno>
<idno type="wicri:Area/Main/Merge">005145</idno>
<idno type="wicri:Area/Main/Curation">004929</idno>
<idno type="wicri:Area/Main/Exploration">004929</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K</title>
<author>
<name sortKey="Yamada, T" sort="Yamada, T" uniqKey="Yamada T" first="T." last="Yamada">T. Yamada</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Correspondence: P.L. McGeer, 2255 Wesbrook Mall, University of B.C., Vancouver, B.C. V6T 1W5</wicri:regionArea>
<wicri:noRegion>B.C. V6T 1W5</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Baimbridge, K G" sort="Baimbridge, K G" uniqKey="Baimbridge K" first="K. G." last="Baimbridge">K. G. Baimbridge</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Physiology, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mcgeer, E G" sort="Mcgeer, E G" uniqKey="Mcgeer E" first="E. G." last="Mcgeer">E. G. Mcgeer</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain Research</title>
<title level="j" type="abbrev">BRES</title>
<idno type="ISSN">0006-8993</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">526</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="303">303</biblScope>
<biblScope unit="page" to="307">307</biblScope>
</imprint>
<idno type="ISSN">0006-8993</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-8993</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Calbindin</term>
<term>Calbindin 1</term>
<term>Calbindins</term>
<term>Cell Count</term>
<term>Cell Survival (physiology)</term>
<term>Corpus Striatum (physiology)</term>
<term>Dopamine (physiology)</term>
<term>Dopaminergic neuron</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nerve Degeneration (physiology)</term>
<term>Nerve Tissue Proteins (metabolism)</term>
<term>Neural Pathways (physiology)</term>
<term>Neurons (metabolism)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson's disease</term>
<term>S100 Calcium Binding Protein G (metabolism)</term>
<term>Strionigral degeneration</term>
<term>Substantia Nigra (metabolism)</term>
<term>Substantia nigra</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Nerve Tissue Proteins</term>
<term>S100 Calcium Binding Protein G</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Dopamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Calbindin 1</term>
<term>Calbindins</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Neurons</term>
<term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Cell Survival</term>
<term>Corpus Striatum</term>
<term>Nerve Degeneration</term>
<term>Neural Pathways</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cell Count</term>
<term>Female</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The distribution of calbindin-D28K (CaBP)-positive neurons was investigated by immunohistochemistry in 4 controls, 5 cases of Parkinson's disease and a single case of strionigral degeneration. CaBP-positive neurons were preferentially localized to the mediodorsal portion of the substantia nigra pars compacta (SNC) in the β layer, while CaBP-negative, melanin-positive neurons were concentrated in the ventrolateral SNC in the α layer. In Parkinson's disease and the case of strionigral degeneration, there was a relative sparing of the CaBP-positive neurons compared with CaBP-negative, pigmented neurons. These data imply that CaBP may confer some protection to SNC dopaminergic neurons against the pathological process which is responsible for Parkinson's disease and strionigral degeneration.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Yamada, T" sort="Yamada, T" uniqKey="Yamada T" first="T." last="Yamada">T. Yamada</name>
</noRegion>
<name sortKey="Baimbridge, K G" sort="Baimbridge, K G" uniqKey="Baimbridge K" first="K. G." last="Baimbridge">K. G. Baimbridge</name>
<name sortKey="Mcgeer, E G" sort="Mcgeer, E G" uniqKey="Mcgeer E" first="E. G." last="Mcgeer">E. G. Mcgeer</name>
<name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
<name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004929 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004929 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:4BD7EEE7C9455A85DA6B7926202C569AB07183AF
   |texte=   Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022